| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 1.71e-08 | 11 | 167 | 5 | GO:0004523 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 7.26e-08 | 14 | 167 | 5 | GO:0003964 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 5.87e-07 | 37 | 167 | 6 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 6.92e-07 | 38 | 167 | 6 | GO:0070001 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 7.04e-07 | 21 | 167 | 5 | GO:0035613 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 2.22e-06 | 46 | 167 | 6 | GO:0016893 | |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | ERVK-6 RNGTT PARP8 ERVK-7 ERVK-10 POLR3B ERVK-8 ERVK-11 PARP12 | 5.44e-06 | 152 | 167 | 9 | GO:0016779 |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 1.35e-05 | 37 | 167 | 5 | GO:0016891 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 1.55e-05 | 38 | 167 | 5 | GO:0034061 | |
| GeneOntologyMolecularFunction | calcium:monoatomic cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration | 2.07e-04 | 3 | 167 | 2 | GO:1905060 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ester bonds | ERVK-6 PLB1 PDE6A RNGTT GDPD3 WRN ERVK-7 ERVK-10 PLA2G4D FANCM PTPRF CPT1C ERVK-8 PLCB2 ERVK-11 DNA2 PPTC7 | 4.42e-04 | 807 | 167 | 17 | GO:0016788 |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 5.27e-04 | 79 | 167 | 5 | GO:0004521 | |
| GeneOntologyMolecularFunction | calcium ion binding | CAPN12 FBLN5 ASAH2 ANXA7 PLA2G4D MICU1 MYL12A BMP1 SLC8A1 FBN1 NRXN1 TLL2 PLCB2 PCDH10 MYL12B RASGRP2 | 5.63e-04 | 749 | 167 | 16 | GO:0005509 |
| GeneOntologyMolecularFunction | neuroligin family protein binding | 6.84e-04 | 5 | 167 | 2 | GO:0097109 | |
| GeneOntologyMolecularFunction | nuclease activity | 7.44e-04 | 231 | 167 | 8 | GO:0004518 | |
| GeneOntologyMolecularFunction | endonuclease activity | 1.00e-03 | 136 | 167 | 6 | GO:0004519 | |
| GeneOntologyMolecularFunction | endopeptidase activity | CAPN12 ERVK-6 NRDC ERVK-7 ERVK-10 BMP1 TLL2 GZMA ERVK-8 ERVK-18 ERVK-25 | 1.02e-03 | 430 | 167 | 11 | GO:0004175 |
| GeneOntologyMolecularFunction | NAD+-protein-cysteine ADP-ribosyltransferase activity | 1.02e-03 | 6 | 167 | 2 | GO:0140803 | |
| GeneOntologyMolecularFunction | four-way junction helicase activity | 1.02e-03 | 6 | 167 | 2 | GO:0009378 | |
| GeneOntologyMolecularFunction | structural molecule activity | ERVK-6 FBLN5 LAMB3 ERVK-7 LMNB2 ERVK-10 KRT79 SSPOP NUP205 FBN1 MRPS21 ERVK-8 ERVK-18 MRPS33 ERVK-25 MUC4 TUBAL3 | 1.32e-03 | 891 | 167 | 17 | GO:0005198 |
| GeneOntologyMolecularFunction | zinc ion binding | ERVK-6 ZCCHC8 ASAH2 ZIM2 ERVK-7 ERVK-10 NR1D1 PGGT1B BMP1 POLR3B RNPEP SYTL4 TLL2 ERVK-8 ZMYM1 ERVK-11 TET3 | 1.32e-03 | 891 | 167 | 17 | GO:0008270 |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 1.66e-03 | 262 | 167 | 8 | GO:0140097 | |
| GeneOntologyBiologicalProcess | DNA integration | 3.88e-08 | 13 | 166 | 5 | GO:0015074 | |
| GeneOntologyBiologicalProcess | DNA-templated DNA replication | ERVK-6 WRN ERVK-7 ERVK-10 BCL6 FANCM ERVK-8 ERVK-11 DNA2 RPA1 | 1.85e-06 | 178 | 166 | 10 | GO:0006261 |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 2.30e-06 | 48 | 166 | 6 | GO:0000731 | |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 5.62e-05 | 83 | 166 | 6 | GO:0006278 | |
| Domain | EGF_1 | FBLN5 NTNG1 LAMB3 SSPOP BMP1 FBN1 NRXN3 NRXN1 TIE1 TLL2 MUC4 | 1.28e-05 | 255 | 160 | 11 | PS00022 |
| Domain | EGF_2 | FBLN5 NTNG1 LAMB3 SSPOP BMP1 FBN1 NRXN3 NRXN1 TIE1 TLL2 MUC4 | 1.83e-05 | 265 | 160 | 11 | PS01186 |
| Domain | EGF_3 | 3.60e-05 | 235 | 160 | 10 | PS50026 | |
| Domain | APC_r | 7.29e-05 | 2 | 160 | 2 | PF05923 | |
| Domain | SAMP | 7.29e-05 | 2 | 160 | 2 | PF05924 | |
| Domain | APC_dom | 7.29e-05 | 2 | 160 | 2 | IPR026831 | |
| Domain | APC_N | 7.29e-05 | 2 | 160 | 2 | IPR032038 | |
| Domain | APC_basic_dom | 7.29e-05 | 2 | 160 | 2 | IPR009234 | |
| Domain | Apc_fam | 7.29e-05 | 2 | 160 | 2 | IPR026818 | |
| Domain | APC_rpt | 7.29e-05 | 2 | 160 | 2 | IPR009223 | |
| Domain | SAMP | 7.29e-05 | 2 | 160 | 2 | IPR009224 | |
| Domain | APC_basic | 7.29e-05 | 2 | 160 | 2 | PF05956 | |
| Domain | APC_N_CC | 7.29e-05 | 2 | 160 | 2 | PF16689 | |
| Domain | EGF-like_CS | 8.67e-05 | 261 | 160 | 10 | IPR013032 | |
| Domain | EGF | 1.97e-04 | 235 | 160 | 9 | SM00181 | |
| Domain | EF-hand_11 | 2.18e-04 | 3 | 160 | 2 | PF08976 | |
| Domain | BMP_1/tolloid-like | 2.18e-04 | 3 | 160 | 2 | IPR015446 | |
| Domain | Na_Ca_Ex | 2.18e-04 | 3 | 160 | 2 | IPR004836 | |
| Domain | Na_Ca_Ex_C-exten | 2.18e-04 | 3 | 160 | 2 | IPR032452 | |
| Domain | IQSEC_PH | 2.18e-04 | 3 | 160 | 2 | IPR033742 | |
| Domain | EF_hand_DJBP | 2.18e-04 | 3 | 160 | 2 | IPR015070 | |
| Domain | Na_Ca_ex_C | 2.18e-04 | 3 | 160 | 2 | PF16494 | |
| Domain | IQ_SEC7_PH | 2.18e-04 | 3 | 160 | 2 | PF16453 | |
| Domain | EGF-like_dom | 3.02e-04 | 249 | 160 | 9 | IPR000742 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 3.03e-04 | 106 | 160 | 6 | IPR000152 | |
| Domain | EGF | 7.61e-04 | 126 | 160 | 6 | PF00008 | |
| Domain | Peptidase_M12A | 1.07e-03 | 6 | 160 | 2 | IPR001506 | |
| Domain | Astacin | 1.07e-03 | 6 | 160 | 2 | PF01400 | |
| Domain | Syndecan | 1.49e-03 | 7 | 160 | 2 | PF01034 | |
| Domain | Syndecan/Neurexin_dom | 1.49e-03 | 7 | 160 | 2 | IPR027789 | |
| Domain | ASX_HYDROXYL | 1.70e-03 | 100 | 160 | 5 | PS00010 | |
| Domain | Calx_beta | 1.97e-03 | 8 | 160 | 2 | SM00237 | |
| Domain | Calx_beta | 2.52e-03 | 9 | 160 | 2 | IPR003644 | |
| Domain | NaCa_Exmemb | 2.52e-03 | 9 | 160 | 2 | IPR004837 | |
| Domain | Na_Ca_ex | 2.52e-03 | 9 | 160 | 2 | PF01699 | |
| Domain | Calx-beta | 2.52e-03 | 9 | 160 | 2 | PF03160 | |
| Domain | Complex1_LYR | 3.14e-03 | 10 | 160 | 2 | IPR008011 | |
| Domain | Complex1_LYR | 3.14e-03 | 10 | 160 | 2 | PF05347 | |
| Domain | SSD | 5.35e-03 | 13 | 160 | 2 | IPR000731 | |
| Domain | SSD | 5.35e-03 | 13 | 160 | 2 | PS50156 | |
| Domain | Dynein_heavy_chain_D4_dom | 6.20e-03 | 14 | 160 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 6.20e-03 | 14 | 160 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 6.20e-03 | 14 | 160 | 2 | IPR013602 | |
| Domain | DHC_N2 | 6.20e-03 | 14 | 160 | 2 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 6.20e-03 | 14 | 160 | 2 | IPR011704 | |
| Domain | PreATP-grasp_dom | 6.20e-03 | 14 | 160 | 2 | IPR016185 | |
| Domain | MT | 6.20e-03 | 14 | 160 | 2 | PF12777 | |
| Domain | AAA_8 | 6.20e-03 | 14 | 160 | 2 | PF12780 | |
| Domain | Neurexin-like | 6.20e-03 | 14 | 160 | 2 | IPR003585 | |
| Domain | 4.1m | 6.20e-03 | 14 | 160 | 2 | SM00294 | |
| Domain | AAA_5 | 6.20e-03 | 14 | 160 | 2 | PF07728 | |
| Domain | EGF_CA | 6.39e-03 | 86 | 160 | 4 | PF07645 | |
| Domain | DHC_fam | 7.12e-03 | 15 | 160 | 2 | IPR026983 | |
| Domain | Dynein_heavy | 7.12e-03 | 15 | 160 | 2 | PF03028 | |
| Domain | - | 7.12e-03 | 15 | 160 | 2 | 1.10.1000.11 | |
| Domain | Dynein_heavy_dom | 7.12e-03 | 15 | 160 | 2 | IPR004273 | |
| Domain | Sec7 | 7.12e-03 | 15 | 160 | 2 | PF01369 | |
| Domain | Sec7_alpha_orthog | 7.12e-03 | 15 | 160 | 2 | IPR023394 | |
| Domain | VWF_type-D | 8.09e-03 | 16 | 160 | 2 | IPR001846 | |
| Domain | Laminin_N | 8.09e-03 | 16 | 160 | 2 | IPR008211 | |
| Domain | SEC7 | 8.09e-03 | 16 | 160 | 2 | PS50190 | |
| Domain | VWFD | 8.09e-03 | 16 | 160 | 2 | PS51233 | |
| Domain | LamNT | 8.09e-03 | 16 | 160 | 2 | SM00136 | |
| Domain | Sec7 | 8.09e-03 | 16 | 160 | 2 | SM00222 | |
| Domain | VWD | 8.09e-03 | 16 | 160 | 2 | SM00216 | |
| Domain | LAMININ_NTER | 8.09e-03 | 16 | 160 | 2 | PS51117 | |
| Domain | Sec7_dom | 8.09e-03 | 16 | 160 | 2 | IPR000904 | |
| Domain | Laminin_N | 8.09e-03 | 16 | 160 | 2 | PF00055 | |
| Domain | PINT | 8.09e-03 | 16 | 160 | 2 | SM00088 | |
| Domain | VWD | 8.09e-03 | 16 | 160 | 2 | PF00094 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | DNAH3 RNGTT DOCK11 IQSEC2 LAMB3 GRIK5 LMNB2 CHML SSPOP NUP205 IVNS1ABP MYL12A IGSF10 PI4KA AGL RPA1 PCDH10 | 1.21e-07 | 736 | 168 | 17 | 29676528 |
| Pubmed | NRDC STXBP5L LAMB3 EPB41L4A SLCO1B1 MICU1 LY6G5B IVNS1ABP IGSF10 SLC8A1 RGS8 TLL2 PRKAA2 TET3 GNPAT GABRA4 | 2.54e-07 | 686 | 168 | 16 | 29987050 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 3.89e-07 | 94 | 168 | 7 | 21542922 | |
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 4.41e-07 | 4 | 168 | 3 | 10469592 | |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 1.10e-06 | 5 | 168 | 3 | 12629516 | |
| Pubmed | 1.19e-06 | 17 | 168 | 4 | 27779093 | ||
| Pubmed | 1.52e-06 | 18 | 168 | 4 | 18664271 | ||
| Pubmed | 3.82e-06 | 7 | 168 | 3 | 9856994 | ||
| Pubmed | 6.09e-06 | 8 | 168 | 3 | 37591863 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | NRDC ACAD9 GPS1 WRN APC PSMD3 KRT79 NUP205 MICU1 IVNS1ABP POLR3B SYTL4 MRPS21 WRAP73 UMPS SEC61A1 MYL12B | 8.28e-06 | 1005 | 168 | 17 | 19615732 |
| Pubmed | MRI1 GPS1 PSMB4 PSMD3 NUP205 SYTL4 SGPL1 MRPS21 MRPS33 CAMSAP1 TUBAL3 XPOT | 1.56e-05 | 547 | 168 | 12 | 37267103 | |
| Pubmed | Integrative predictive model of coronary artery calcification in atherosclerosis. | 1.68e-05 | 229 | 168 | 8 | 19948975 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 26035354 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 15539558 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 37543682 | ||
| Pubmed | Neurexin I alpha is a major alpha-latrotoxin receptor that cooperates in alpha-latrotoxin action. | 2.32e-05 | 2 | 168 | 2 | 9430716 | |
| Pubmed | IKKα is required in the intestinal epithelial cells for tumour stemness. | 2.32e-05 | 2 | 168 | 2 | 29438366 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 19658047 | ||
| Pubmed | Roles of Na(+)/Ca(2+) exchanger isoforms NCX1 and NCX2 in motility in mouse ileum. | 2.32e-05 | 2 | 168 | 2 | 27411318 | |
| Pubmed | Na+/Ca2+ exchanger contributes to stool transport in mice with experimental diarrhea. | 2.32e-05 | 2 | 168 | 2 | 27928109 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 24505135 | ||
| Pubmed | Dynamic recruitment of active proteasomes into polyglutamine initiated inclusion bodies. | 2.32e-05 | 2 | 168 | 2 | 24291262 | |
| Pubmed | Genetic knockout and pharmacologic inhibition of NCX2 cause natriuresis and hypercalciuria. | 2.32e-05 | 2 | 168 | 2 | 25498502 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 25078964 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 26823757 | ||
| Pubmed | Nardilysin controls intestinal tumorigenesis through HDAC1/p53-dependent transcriptional regulation. | 2.32e-05 | 2 | 168 | 2 | 29669932 | |
| Pubmed | Dna2 nuclease-helicase structure, mechanism and regulation by Rpa. | 2.32e-05 | 2 | 168 | 2 | 26491943 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 27694902 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 26787195 | ||
| Pubmed | Functional and physical interaction between WRN helicase and human replication protein A. | 2.32e-05 | 2 | 168 | 2 | 10373438 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 31461648 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 18593712 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 14499497 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 35255004 | ||
| Pubmed | APC2 is critical for ovarian WNT signalling control, fertility and tumour suppression. | 2.32e-05 | 2 | 168 | 2 | 31291912 | |
| Pubmed | Interferon-alpha-induced endogenous superantigen. a model linking environment and autoimmunity. | 2.32e-05 | 2 | 168 | 2 | 11672541 | |
| Pubmed | 2.42e-05 | 175 | 168 | 7 | 28071719 | ||
| Pubmed | 4.37e-05 | 192 | 168 | 7 | 20602615 | ||
| Pubmed | Defining the Protein-Protein Interaction Network of the Human Protein Tyrosine Phosphatase Family. | RNGTT DOCK11 ACAD9 GPS1 ZBTB43 NUP205 LY6G5B SERPINB6 DCAF10 SGPL1 MRPS21 SNX18 MRPS33 SEC61A1 XPOT | 5.00e-05 | 931 | 168 | 15 | 27432908 |
| Pubmed | 5.10e-05 | 42 | 168 | 4 | 24997765 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 38891114 | ||
| Pubmed | IKKalpha and IKKbeta regulation of DNA damage-induced cleavage of huntingtin. | 6.94e-05 | 3 | 168 | 2 | 19488402 | |
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 21597006 | ||
| Pubmed | SGPL1 stimulates VPS39 recruitment to the mitochondria in MICU1 deficient cells. | 6.94e-05 | 3 | 168 | 2 | 35452878 | |
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 18824173 | ||
| Pubmed | AATF/Che-1 acts as a phosphorylation-dependent molecular modulator to repress p53-driven apoptosis. | 6.94e-05 | 3 | 168 | 2 | 22909821 | |
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 20696710 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 27612385 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 21382638 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 16406382 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 9971820 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 25122754 | ||
| Pubmed | Fibulin-5 interacts with fibrillin-1 molecules and microfibrils. | 6.94e-05 | 3 | 168 | 2 | 15790312 | |
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 31005376 | ||
| Pubmed | Genetic analysis of the role of proteolysis in the activation of latent myostatin. | 6.94e-05 | 3 | 168 | 2 | 18286185 | |
| Pubmed | The downregulation of NCXs is positively correlated with the prognosis of stage II-IV colon cancer. | 6.94e-05 | 3 | 168 | 2 | 34127021 | |
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 11942626 | ||
| Pubmed | Nuclear translocation of AMPK-alpha1 potentiates striatal neurodegeneration in Huntington's disease. | 6.94e-05 | 3 | 168 | 2 | 21768291 | |
| Pubmed | Regulated Dynamic Trafficking of Neurexins Inside and Outside of Synaptic Terminals. | 6.94e-05 | 3 | 168 | 2 | 26446217 | |
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 19262689 | ||
| Pubmed | Analysis of the human neurexin genes: alternative splicing and the generation of protein diversity. | 6.94e-05 | 3 | 168 | 2 | 11944992 | |
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 33058888 | ||
| Pubmed | Important contribution of alpha-neurexins to Ca2+-triggered exocytosis of secretory granules. | 6.94e-05 | 3 | 168 | 2 | 17035546 | |
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 9448462 | ||
| Pubmed | Deletion of α-neurexin II results in autism-related behaviors in mice. | 6.94e-05 | 3 | 168 | 2 | 25423136 | |
| Pubmed | Endogenous β-neurexins on axons and within synapses show regulated dynamic behavior. | 6.94e-05 | 3 | 168 | 2 | 34133920 | |
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 26714588 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 29594857 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 18385088 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 30858964 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 23986473 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 15825828 | ||
| Pubmed | DANCE/fibulin-5 promotes elastic fiber formation in a tropoelastin isoform-dependent manner. | 6.94e-05 | 3 | 168 | 2 | 19167375 | |
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 10516026 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 19288496 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 28013231 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 21107010 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 31812984 | ||
| Pubmed | Structure and evolution of neurexin genes: insight into the mechanism of alternative splicing. | 6.94e-05 | 3 | 168 | 2 | 12036300 | |
| Pubmed | β-Neurexins Control Neural Circuits by Regulating Synaptic Endocannabinoid Signaling. | 6.94e-05 | 3 | 168 | 2 | 26213384 | |
| Pubmed | Neurexin gene family variants as risk factors for autism spectrum disorder. | 6.94e-05 | 3 | 168 | 2 | 29045040 | |
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 38571813 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 35173587 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 34843459 | ||
| Pubmed | Aberrant Amygdala-Dependent Cued Fear Memory in Na+/Ca2+ Exchanger 1 Heterozygous Mice. | 6.94e-05 | 3 | 168 | 2 | 30324228 | |
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 19690388 | ||
| Pubmed | Sodium-calcium exchange in intracellular calcium handling of human airway smooth muscle. | 6.94e-05 | 3 | 168 | 2 | 21858195 | |
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 30808715 | ||
| Pubmed | Immunosuppressive drugs, immunophilins, and functional expression of NCX isoforms. | 6.94e-05 | 3 | 168 | 2 | 23224887 | |
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 23224890 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 23224882 | ||
| Pubmed | Neurexins are differentially expressed in the embryonic nervous system of mice. | 6.94e-05 | 3 | 168 | 2 | 7722633 | |
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 17317768 | ||
| Pubmed | Identification and characterization of SMARCAL1 protein complexes. | 6.94e-05 | 3 | 168 | 2 | 23671665 | |
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 23840886 | ||
| Pubmed | p53 modulates RPA-dependent and RPA-independent WRN helicase activity. | 6.94e-05 | 3 | 168 | 2 | 15735006 | |
| Pubmed | ZCCHC8 ACAD9 ANXA7 PSMB4 PSMD3 HMGCR MCCC1 CHUK NUP205 POLR3B SF3B3 SGPL1 MRPS21 MRPS33 UMPS RPA1 SEC61A1 PARP12 XPOT | 7.35e-05 | 1440 | 168 | 19 | 30833792 | |
| Pubmed | PDE6A TTC16 PARP8 GPS1 PSMD3 LMNB2 PLA2G4D KRT79 CHUK NUP205 RUNDC3A C6orf118 NRXN3 SF3B3 NRXN1 MED11 MYH15 SEC61A1 CFAP46 | 7.48e-05 | 1442 | 168 | 19 | 35575683 | |
| Pubmed | OL-Protocadherin is essential for growth of striatal axons and thalamocortical projections. | 8.56e-05 | 18 | 168 | 3 | 17721516 | |
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | ZCCHC8 ACAD9 PSMD3 NUP205 SF3B3 PTPRF RPA1 SEC61A1 TUBAL3 PPTC7 XPOT | 1.16e-04 | 573 | 168 | 11 | 28330616 |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-NK_CD56bright|Leuk-UTI / Disease, Lineage and Cell Type | 1.15e-07 | 157 | 162 | 8 | db0057741d06e212a9543cb4b011659b79efeafc | |
| ToppCell | facs-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.02e-07 | 195 | 162 | 8 | c4648c0332c3826776f9ad3f5f803dbac2b4c0c0 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Artery|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.29e-07 | 200 | 162 | 8 | 77ae679c35d3b9e2b620f34129f3a8d47e922c65 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / Treatment groups by lineage, cell group, cell type | 7.29e-07 | 200 | 162 | 8 | b17eb1587ca86c3d40515128a00a8d8fd787fccf | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Artery|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.29e-07 | 200 | 162 | 8 | b1ff8d61b567f85006d6d20093f9c803b6d34674 | |
| ToppCell | droplet-Marrow-nan-18m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.53e-06 | 174 | 162 | 7 | 55cc8300489d11322724159ec7d0e1d32a702e91 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.25e-06 | 179 | 162 | 7 | 5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_NK-NK_bright-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.58e-06 | 181 | 162 | 7 | 4795833e0ec49287bd7809ecfe523fc527565fba | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_NK-NK_bright|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.58e-06 | 181 | 162 | 7 | 208cdccc2f0d0f2d8ec321064c63aed206d46c32 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.10e-06 | 184 | 162 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.10e-06 | 184 | 162 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.10e-06 | 184 | 162 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | 18-Airway-Epithelial-Neuroendocrine|Airway / Age, Tissue, Lineage and Cell class | 6.08e-06 | 189 | 162 | 7 | 144beb01b908f2cd0e04513fb84d817e0c3c124e | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.08e-06 | 189 | 162 | 7 | b028466fcd36fdeceec752e55a24286a1cd62ae4 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_NK-NK_bright|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.21e-06 | 194 | 162 | 7 | aee60da2e7aed161cdd4abbfad6864665aaa8f5c | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_NK-NK_bright-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.21e-06 | 194 | 162 | 7 | afa8d29924719af3bc5f48f22cf66d5e8f9e3e37 | |
| ToppCell | normal_Lymph_Node-T/NK_cells-NK|normal_Lymph_Node / Location, Cell class and cell subclass | 7.71e-06 | 196 | 162 | 7 | 00ab4a1547752d419aa720b39b94a4ab2ede963a | |
| ToppCell | wk_20-22-Epithelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 7.97e-06 | 197 | 162 | 7 | 468071c1911cdf8e8806a78dbceb95379e28ae91 | |
| ToppCell | Mild/Remission-B_memory-3|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.24e-06 | 198 | 162 | 7 | 44906dbf99ddd53335e2d32082ff7e77d91baaeb | |
| ToppCell | normal_Lymph_Node-T/NK_cells-NK|T/NK_cells / Location, Cell class and cell subclass | 8.24e-06 | 198 | 162 | 7 | 75e94298bf03d755fef46df685437d0d29fdbca9 | |
| ToppCell | frontal_cortex-Non-neuronal-oligodendrocyte-Oligo-Oligo_Synpr|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.11e-05 | 137 | 162 | 6 | b03f19b233c1c809f2cd2b4a7642eeaf254a6289 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-05 | 148 | 162 | 6 | b4632029ebd14969bda59a1bd1454eadb8efe563 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-05 | 148 | 162 | 6 | ba277c898678dd36f8dc1d681301c71901b89055 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_D2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.85e-05 | 150 | 162 | 6 | ecc4fc94958cf2378dd003966dccba81b3c00f8e | |
| ToppCell | PND01-03-samps-Myeloid-Macrophage-macrophage-B|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 2.00e-05 | 152 | 162 | 6 | 5ce8920aedd39a4daf7082153b5e213707c14227 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-Epcam____proximal_tube_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-05 | 158 | 162 | 6 | 1d78578dc1f8ba43dacdccae1082c0b9d749f64d | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 2.96e-05 | 163 | 162 | 6 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | droplet-Lung-nan-21m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-05 | 166 | 162 | 6 | 21ba5fd755c0fb31ada42a1b5d60bede0153323d | |
| ToppCell | wk_20-22-Hematologic-Myeloid-GMP|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.28e-05 | 166 | 162 | 6 | d96e88e73a40205f32cebd7e54ca1ff09ee1e7e8 | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.50e-05 | 168 | 162 | 6 | fa7c0303918cea04e3f4c4f3cb079be19004d214 | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.50e-05 | 168 | 162 | 6 | 7edcab103c69e928d5c19a0d218ffb3ae32f9e70 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.26e-05 | 174 | 162 | 6 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | PND28-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.84e-05 | 178 | 162 | 6 | a3af5d9c55858e36be0498081029ecb0acaeb3d3 | |
| ToppCell | control-NK_CD56bright|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.84e-05 | 178 | 162 | 6 | f3d0bc9a39ed94785676f10c285c5b031bc93aae | |
| ToppCell | PND28-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.84e-05 | 178 | 162 | 6 | b3b88989bd602cfb55bb5c47731deb99288a8952 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.64e-05 | 183 | 162 | 6 | 7e2bac8b005155888ff4b41ef2e1d975dc17abc7 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.84e-05 | 113 | 162 | 5 | ec4b89e727e1b921b9cb17443774955b95814dd4 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_NK-NK_bright-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.99e-05 | 185 | 162 | 6 | 3b2da51aec057b462749ae39afb8f253afcf38d5 | |
| ToppCell | 18-Distal-Epithelial-Epithelial|Distal / Age, Tissue, Lineage and Cell class | 5.99e-05 | 185 | 162 | 6 | d2a266724f3f70f746a78034f308d98f8b7a66e3 | |
| ToppCell | Mild-NK|World / Disease group and Cell class | 5.99e-05 | 185 | 162 | 6 | 0565b7c464e1a09e596f5a0b363d2dc9b55c3c50 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_bright-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.17e-05 | 186 | 162 | 6 | 5ad37549592eab23f166196ebf0cb9c8ddf26082 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-neurons_B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.17e-05 | 186 | 162 | 6 | 15f2e5905486e33f6f7b3b3e9758a0559e8c61ee | |
| ToppCell | lymphoid-NK_cell-TNFRSF18+IL7R+_NK_cell|lymphoid / Lineage, cell class and subclass | 6.36e-05 | 187 | 162 | 6 | 99dfa50f6325b0d66d23ee8dcaa6437e7161628a | |
| ToppCell | facs-MAT-Fat-3m|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-05 | 188 | 162 | 6 | 7da9750255efbc5cf9aed7e3105a337fac63b9f0 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_bright|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.74e-05 | 189 | 162 | 6 | 3e148accffc6ab249fb0dff7f3bf5a7fff9da773 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.94e-05 | 190 | 162 | 6 | aed65d584ca0c25f6a8313c66b421a6618af82ea | |
| ToppCell | Control-Epithelial-Ciliated_cells|Control / Condition, Lineage and Cell class | 7.15e-05 | 191 | 162 | 6 | ea1d2c6838119b7019e9a2ff71d6212262b51b57 | |
| ToppCell | ASK454-Epithelial-Secretory|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.15e-05 | 191 | 162 | 6 | c63c781e7e93265e591cf494cb4ce8ed797c24fb | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Artery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.15e-05 | 191 | 162 | 6 | 4b3d5157344dbfbf4fab518611cd9fa37fac7bd9 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.15e-05 | 191 | 162 | 6 | e81cd65dbf0ef1c2ab7088f73ce605d456dd3a7a | |
| ToppCell | Control-Epithelial|Control / Condition, Lineage and Cell class | 7.15e-05 | 191 | 162 | 6 | 6228302febdb3dffe37dece7062d27ac9ccc6d4b | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.35e-05 | 192 | 162 | 6 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.35e-05 | 192 | 162 | 6 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.35e-05 | 192 | 162 | 6 | 0dc1f46e40346ed0b286e53b106a812441575100 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.57e-05 | 193 | 162 | 6 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | Mild_COVID-19-T/NK-NK|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 7.57e-05 | 193 | 162 | 6 | 9c455d9d845fa230e9a61d9a5f9d6a2ccf5d7350 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-goblet-Goblet_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.79e-05 | 194 | 162 | 6 | 49cc5f5de4380302100e8cd937f08abe317ac75e | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-goblet|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.79e-05 | 194 | 162 | 6 | fb935df966c451e659b8bde281f8aebcb632f6cf | |
| ToppCell | normal-na-Lymphocytic_NK-NK_bright-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 7.79e-05 | 194 | 162 | 6 | dc4aeee379423827e8d291cffe4dbdf2ff6d0bbe | |
| ToppCell | Control-MAIT|Control / Disease condition and Cell class | 7.79e-05 | 194 | 162 | 6 | ed99f8bff6766795fc396990604366f49ff58181 | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-NK|Leuk-UTI / Disease, Lineage and Cell Type | 7.79e-05 | 194 | 162 | 6 | 36afc4e48d267be3b8aa1e33fad043bcd54c6bc5 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_NK-NK_CD56bright_CD16-|lymph-node_spleen / Manually curated celltypes from each tissue | 7.79e-05 | 194 | 162 | 6 | 8a596f25f6bfa5baaa2f52d80ad92f2925713398 | |
| ToppCell | normal-na-Lymphocytic_NK-NK_bright|normal / PBMC cell types (v2) per disease, treatment status, and sex | 7.79e-05 | 194 | 162 | 6 | 8c5f716ce05c1f187de63c1b6948eb9f90ff34fe | |
| ToppCell | BLOOD--(0)_NK_cells_(CD56bright-like)| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.79e-05 | 194 | 162 | 6 | 8d4368d546bba17a420e172bfb5f1f337fe23c44 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 7.79e-05 | 194 | 162 | 6 | b46c54802b8d1e0a0a17f9ed8e82eaf5e7f4849d | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-goblet|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.01e-05 | 195 | 162 | 6 | c5f33b420c9ac14dc67fea632b8c2bc2442cbf3d | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-NK_cell-NK|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.01e-05 | 195 | 162 | 6 | 90c77b7f245b1bf80ba293583f8fe343b14c7f67 | |
| ToppCell | 15-Airway-Epithelial-Epithelial|Airway / Age, Tissue, Lineage and Cell class | 8.01e-05 | 195 | 162 | 6 | 56356a9aeb67b50a74425be2cd9c50d31416c1b3 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-NK_cell|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.01e-05 | 195 | 162 | 6 | 4eb13aa9fc496caca6e0a4fb80d11a60cf2511b0 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.01e-05 | 195 | 162 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-goblet-Goblet_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.01e-05 | 195 | 162 | 6 | 219c5d0cde7f6082755154f54db221413ec555cb | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.01e-05 | 195 | 162 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-NK_cell-NK-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.01e-05 | 195 | 162 | 6 | 89d832d1715f2720caa8cdd1e7ef847d79642556 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-goblet|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.24e-05 | 196 | 162 | 6 | c2d17630f7bfc9e727de55e093c17fddac61b61f | |
| ToppCell | lymphoid-T_cell-Regulatory_T_cell|World / Lineage, cell class and subclass | 8.24e-05 | 196 | 162 | 6 | 42a4d706382be33d552ece1d0598d073857a8d4e | |
| ToppCell | Control-Lymphocyte-T_NK-NK|Control / Disease, Lineage and Cell Type | 8.24e-05 | 196 | 162 | 6 | 65838fddc920cdcecefe823f3ce1c95a7e50e82b | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.24e-05 | 196 | 162 | 6 | 1eb14182ef26e6141f510d397b00bf8a12efda3e | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-goblet-Goblet_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.24e-05 | 196 | 162 | 6 | 54c30023d04e7265373647f56fc93885804938b0 | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 8.24e-05 | 196 | 162 | 6 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A-Branch_A2_(IPAN/IN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.47e-05 | 197 | 162 | 6 | 27c044833e471a312a572e0b1c83e4bc8a36e896 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_A-Branch_A2_(IPAN/IN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.47e-05 | 197 | 162 | 6 | f7eaac1c321710a55e09ffb047a7db2baf7b7e28 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.47e-05 | 197 | 162 | 6 | 3a0e97bfebe82f9687d518baaad7f20d0ffea8a1 | |
| ToppCell | COVID-19-Epithelial|COVID-19 / Condition, Lineage and Cell class | 8.47e-05 | 197 | 162 | 6 | 18fd7344628a87d5c7ef5efb66e260a4136245bf | |
| ToppCell | (0)_NK_cells|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 8.71e-05 | 198 | 162 | 6 | c91c3ccba118dffb12c0bf8036f51fc76f0e305d | |
| ToppCell | Caecum-(0)_NK_cell|Caecum / shred on region, Cell_type, and subtype | 8.96e-05 | 199 | 162 | 6 | 9ffff5c4ca10572d3c57b2ff1ca5415224b67cbe | |
| ToppCell | mLN-(0)_NK_cell-(00)_NK|mLN / shred on region, Cell_type, and subtype | 8.96e-05 | 199 | 162 | 6 | 59d8e4f57580c7273308c32e5308fc1d704b1f6d | |
| ToppCell | mLN-NK_cell-NK|mLN / Region, Cell class and subclass | 8.96e-05 | 199 | 162 | 6 | cc9836b8d18edabe8849a3e948b84d954ef68c48 | |
| ToppCell | Caecum-NK_cell-NK|Caecum / Region, Cell class and subclass | 8.96e-05 | 199 | 162 | 6 | e980998aa401c092d7d52575c97b95f908ecfd7b | |
| ToppCell | mLN-NK_cell|mLN / Region, Cell class and subclass | 8.96e-05 | 199 | 162 | 6 | dcc1d9a3f6f0e64f111d18386bfe5b154e9d5bbe | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.96e-05 | 199 | 162 | 6 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | mLN-(0)_NK_cell|mLN / shred on region, Cell_type, and subtype | 8.96e-05 | 199 | 162 | 6 | 05f5ae4c049f242131a7f59bcce4b18ed52f11be | |
| ToppCell | Caecum-(0)_NK_cell-(00)_NK|Caecum / shred on region, Cell_type, and subtype | 8.96e-05 | 199 | 162 | 6 | f5a44272e8a3c1ffeae61b478c3983df13bc9d53 | |
| ToppCell | Caecum-NK_cell|Caecum / Region, Cell class and subclass | 8.96e-05 | 199 | 162 | 6 | 2dffadf1c24169a9cb7f2bc83176d1fec9c6f77f | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_CD56bright|Control / Disease, condition lineage and cell class | 9.21e-05 | 200 | 162 | 6 | d843fe0781c7699afead4429c526441c6fdb8cba | |
| ToppCell | Control_saline-Endothelial-Endothelial-Artery|Control_saline / Treatment groups by lineage, cell group, cell type | 9.21e-05 | 200 | 162 | 6 | 65b71f1e8da5c3750fcd0a2e66d9ef3125a3f78a | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Artery|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.21e-05 | 200 | 162 | 6 | ac9ead34afa14067171833f5c277eaf06db7b02e | |
| ToppCell | mild-NK_CD56bright|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.21e-05 | 200 | 162 | 6 | a195bc6784346f706d4cd5b740adac1d950ce88a | |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-T/NK-NK|Leuk-UTI / Disease, condition lineage and cell class | 9.21e-05 | 200 | 162 | 6 | bb37fed4872e71f413ae7c4aa12586fa31075334 | |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-T/NK-NK_CD56bright|Leuk-UTI / Disease, condition lineage and cell class | 9.21e-05 | 200 | 162 | 6 | 1d152e9e0170b4efe42d87b8c09e3ca3ef2ae5d7 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l14|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.22e-04 | 132 | 162 | 5 | 14a512f433315892bf0326419f23d0d5919d01ec | |
| Disease | Schizophrenia | DAOA ERBB3 CYP2E1 LYRM4 GPS1 APC NTNG1 GRIK5 NRXN3 NRXN1 MLC1 PI4KA UCP2 ERVK-8 KIF17 GNPAT GABRA4 | 7.91e-06 | 883 | 162 | 17 | C0036341 |
| Disease | familial adenomatous polyposis 1 (implicated_via_orthology) | 3.00e-05 | 2 | 162 | 2 | DOID:0080409 (implicated_via_orthology) | |
| Disease | drug-induced hepatitis (implicated_via_orthology) | 3.00e-05 | 2 | 162 | 2 | DOID:2044 (implicated_via_orthology) | |
| Disease | Intellectual Disability | 3.93e-05 | 447 | 162 | 11 | C3714756 | |
| Disease | complex cortical dysplasia with other brain malformations (is_implicated_in) | 1.78e-04 | 4 | 162 | 2 | DOID:0090131 (is_implicated_in) | |
| Disease | Werner syndrome (implicated_via_orthology) | 2.96e-04 | 5 | 162 | 2 | DOID:5688 (implicated_via_orthology) | |
| Disease | Bipolar Disorder | 3.22e-04 | 477 | 162 | 10 | C0005586 | |
| Disease | Movement Disorders | 5.34e-04 | 29 | 162 | 3 | C0026650 | |
| Disease | Myopathy | 5.91e-04 | 30 | 162 | 3 | C0026848 | |
| Disease | colorectal cancer (implicated_via_orthology) | 5.91e-04 | 30 | 162 | 3 | DOID:9256 (implicated_via_orthology) | |
| Disease | Profound Mental Retardation | 1.04e-03 | 139 | 162 | 5 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 1.04e-03 | 139 | 162 | 5 | C0025363 | |
| Disease | Mental deficiency | 1.04e-03 | 139 | 162 | 5 | C0917816 | |
| Disease | sex interaction measurement, longitudinal BMI measurement | 1.31e-03 | 10 | 162 | 2 | EFO_0005937, EFO_0008343 | |
| Disease | Colorectal Carcinoma | CALCOCO2 DNAH3 PARP8 APC2 WRN APC NTNG1 LAMB3 LMNB2 UMPS PHIP | 1.79e-03 | 702 | 162 | 11 | C0009402 |
| Disease | Charcot-Marie-Tooth disease (is_implicated_in) | 1.91e-03 | 12 | 162 | 2 | DOID:10595 (is_implicated_in) | |
| Disease | Alzheimer disease, dementia | 1.91e-03 | 12 | 162 | 2 | MONDO_0001627, MONDO_0004975 | |
| Disease | myopathy (implicated_via_orthology) | 2.34e-03 | 48 | 162 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | asthma, body mass index | 2.61e-03 | 14 | 162 | 2 | EFO_0004340, MONDO_0004979 | |
| Disease | amyotrophic lateral sclerosis, age at onset | 3.00e-03 | 15 | 162 | 2 | EFO_0004847, MONDO_0004976 | |
| Disease | Alzheimer disease, Cognitive impairment | 3.00e-03 | 15 | 162 | 2 | HP_0100543, MONDO_0004975 | |
| Disease | myocardial infarction | 3.31e-03 | 350 | 162 | 7 | EFO_0000612 | |
| Disease | Cardiovascular Abnormalities | 3.42e-03 | 16 | 162 | 2 | C0243050 | |
| Disease | Lung Neoplasms | 3.53e-03 | 265 | 162 | 6 | C0024121 | |
| Disease | Malignant neoplasm of lung | 3.60e-03 | 266 | 162 | 6 | C0242379 | |
| Disease | Benign neoplasm of stomach | 3.86e-03 | 17 | 162 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 3.86e-03 | 17 | 162 | 2 | C0496905 | |
| Disease | Multiple congenital anomalies | 3.86e-03 | 17 | 162 | 2 | C0000772 | |
| Disease | Carcinoma in situ of stomach | 3.86e-03 | 17 | 162 | 2 | C0154060 | |
| Disease | microglial activation measurement | 4.22e-03 | 59 | 162 | 3 | EFO_0010940 | |
| Disease | mean platelet volume | NRDC DOCK11 RTTN STAC2 SYTL4 PI4KA UCP2 MRPS21 KIF28P UMPS CHST2 PHIP HTT | 4.25e-03 | 1020 | 162 | 13 | EFO_0004584 |
| Disease | Schizophrenia | 4.33e-03 | 18 | 162 | 2 | cv:C0036341 | |
| Disease | Hydrops Fetalis | 4.82e-03 | 19 | 162 | 2 | C0020305 | |
| Disease | colorectal cancer, inflammatory bowel disease | 4.82e-03 | 19 | 162 | 2 | EFO_0003767, MONDO_0005575 | |
| Disease | Lymphoma, Follicular | 5.33e-03 | 20 | 162 | 2 | C0024301 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RSLYNRGFSLLIMKN | 421 | P21860 | |
| SGMLSIISERRNATY | 111 | Q01362 | |
| TMYAQRRISTILFGA | 351 | Q9H4A4 | |
| RRIMNQASEFYLASS | 331 | P54646 | |
| SLLMRNVTRNDTGSY | 106 | P31997 | |
| MRNSYRFLASSLSVV | 1 | P12544 | |
| YGMTAVLSRASRSIR | 541 | Q9H845 | |
| DSLGLYRDRIQMAST | 456 | Q8IYW2 | |
| MEQLFSQYGRIITSR | 141 | Q14576 | |
| YSRLMDTNVRFSAEL | 521 | O94989 | |
| EAYSRMANRDLLSSV | 381 | P20073 | |
| LATGSRMFLRFYSDN | 831 | P13497 | |
| VTSMADSLYNIRLLR | 276 | Q5T5Y3 | |
| YLRELLTTMGDRFTD | 121 | P19105 | |
| ALYFNMRDSSGISRS | 551 | P26374 | |
| VQAFEMLASRALSRY | 161 | Q96AH8 | |
| MLASRALSRYQSILE | 166 | Q96AH8 | |
| RRFSLTTLRNYGMGK | 126 | P05181 | |
| MLGSYGSLARFRNIS | 71 | P28070 | |
| MRYLRTSQDFLFSQL | 1081 | Q92621 | |
| QSLGERMNTFVRYLL | 126 | Q9NPC2 | |
| AYRLGTLDMRAFLRN | 5196 | Q99102 | |
| MLSGFLCRDRSISYS | 81 | Q8NGM9 | |
| MGADSLQLFRSRYTL | 6 | P59103 | |
| LLSRSYSSNLRMEEL | 406 | Q8N3A8 | |
| MGLLVDLTNTSRFYD | 61 | O60942 | |
| VSYFLRSSSVLGGRM | 481 | Q7LDG7 | |
| SYRNFASCMGDSRLL | 136 | Q9Y6Y0 | |
| YSFLDLFRARDNMRG | 216 | O95528 | |
| RNLYIRFQSRSGDAM | 641 | P04035 | |
| YSRLFQGQRAAMLSL | 441 | O15111 | |
| RMRLESLSYQLSGLQ | 311 | Q03252 | |
| QGILTRLYSRAFIMA | 131 | Q9NR71 | |
| AYRALRGLRSFMSAN | 271 | Q5U4P2 | |
| SFRQSFSLYGMQVLL | 801 | Q6DN90 | |
| MLERKYGGSFLSRRA | 336 | Q5JU85 | |
| EAYLGSMRSTLDRLQ | 196 | Q5XKE5 | |
| LQRKSSIFSYRDGMR | 656 | Q8IYD8 | |
| ITRMGLTNFTLNYLR | 191 | O43679 | |
| NRQLLFREYLDGSSM | 91 | Q96D98 | |
| RITERQFGGMLLAYS | 321 | Q9BPX6 | |
| ELEREFSSNMYLSRL | 216 | Q9BZM3 | |
| FSSNMYLSRLRRIEI | 221 | Q9BZM3 | |
| LFMYRTRNGIAELAT | 96 | P16499 | |
| QYAASYSGLMRIERL | 46 | Q13098 | |
| ARDNFRTMTSLYGSI | 141 | Q5QP82 | |
| RELAAFLTGMNESRY | 281 | Q11130 | |
| MGSSSENLLSRLRFL | 351 | Q6UY01 | |
| FRFMSQRAYGLLVAT | 711 | Q9Y4C0 | |
| TYVMSNLFSILRGDS | 286 | P63132 | |
| SRAFGRYSNMEESLL | 191 | P42356 | |
| RNGTILYTMRLTISA | 156 | P48169 | |
| ALGSYAMLSIFFLRR | 11 | Q7L5L3 | |
| DSYNMFENGSFLRRR | 151 | Q99958 | |
| FRSQRAYGILMATTS | 746 | Q9ULB1 | |
| LTYSIVRGNEMNLFR | 616 | Q9P2E7 | |
| LSLRRSLSYVIQGMA | 76 | Q8N1E6 | |
| TYAMSNLFSILRGDS | 286 | P63135 | |
| TYAMSNLFSILRGDS | 286 | Q9BXR3 | |
| FNAMTYGATQARRLS | 346 | Q9H0J9 | |
| MFSVLSYGRLVARAV | 1 | Q8NI37 | |
| TYAMSNLFSILRGDS | 286 | Q9QC07 | |
| MFLSRTTYSLQELGA | 496 | P20393 | |
| RYRLLMSDGLNTLSS | 41 | P27694 | |
| YESAMTRLFLEGRTE | 586 | Q8TCG5 | |
| ALRRYAGMTLTNLTF | 461 | O95996 | |
| YLRQNSMGLFSALRH | 216 | Q6ZSI9 | |
| SFYTLDSLNLRARSM | 1811 | P42858 | |
| YSLLDRFRLSTMQDS | 2056 | P42858 | |
| YNSLVRLMETDFSGL | 66 | Q6WRI0 | |
| SLMGKNFRSYLLDLR | 126 | Q9BWL3 | |
| STRNEASALLYLLMR | 1496 | Q5JSL3 | |
| LLGAASMVLDYTTRR | 706 | Q9Y223 | |
| SLAAGRMSRSSYNLV | 336 | O15228 | |
| SLYSMGFLDSRSLAQ | 1566 | Q8TD57 | |
| LSSSGRRCQDLRMSY | 2046 | P35555 | |
| MSRRSADASQRSLAY | 376 | Q8TF40 | |
| RAILSARSSYFAAML | 221 | Q5XKL5 | |
| DYTGALAVFTRMQRL | 196 | P23610 | |
| VRSIGLMFQNSLYAT | 241 | Q02318 | |
| LAGATSADRYRMFLR | 206 | Q5T5N4 | |
| ENSRLLSYMGLDFNS | 341 | Q13137 | |
| LLDFMYTSRLNLREG | 86 | P41182 | |
| SGRRLNISYTRNMTL | 541 | Q96RQ3 | |
| LARRASALLYAGESM | 371 | Q9Y2E5 | |
| MTTATRQEVLGLYRS | 1 | O43325 | |
| MAASSRAQVLSLYRA | 1 | Q9HD34 | |
| SFAELRRMYLFLNSS | 171 | Q8NDX9 | |
| DRSFNGLLTMYQRKR | 686 | Q13751 | |
| ADRRLRLLGTYVAMS | 21 | Q9NYC9 | |
| FTILYRDMDVVSGRS | 346 | Q9UBX5 | |
| LGLNRSDYMFQRSAD | 121 | P48637 | |
| RVLNSRYAFLLESTM | 711 | Q16478 | |
| RGLDMSRVIFYSAQI | 286 | Q8WTQ7 | |
| RTVLSTGMDNRYLVL | 36 | P51530 | |
| YSGRTALQMSRDLSI | 321 | Q9HCS5 | |
| STFERLMSINYLGSV | 136 | Q06136 | |
| YQSMNTARGQLFRLR | 911 | B7ZC32 | |
| MATYSLANERLRALE | 1 | Q9P086 | |
| LMTYGRRQFQSLDTT | 376 | O95954 | |
| TNILALYTGIMSSFR | 496 | Q3KNS1 | |
| TLYRFQLAARSDMGV | 576 | P10586 | |
| ILYTILQMNSATGRR | 251 | Q8NGS6 | |
| YMAALETELSGRLRS | 211 | Q86XP0 | |
| YRLMLSRSNSENIAS | 936 | Q9P2E2 | |
| DYLRELLTTMGDRFT | 121 | O14950 | |
| RLRNMASLYGQLDTT | 236 | Q9Y2I2 | |
| AITYIRRSMSYDNGL | 196 | P53609 | |
| TTRRFYDSGAIMLRD | 151 | Q59EK9 | |
| EYAFRMSRLSARLFG | 6 | Q9Y291 | |
| AVTRMSFYLLNDRLS | 1091 | Q86VV8 | |
| RFAYRTGSEIIRMSL | 126 | Q96C24 | |
| RFLRSKMYLDLLSQS | 161 | P57771 | |
| FRASRSNNFYLAMLL | 611 | Q7Z5M5 | |
| YRNRTRGSSRSLMEF | 3061 | A2VEC9 | |
| LQLANSYGLFRRMTG | 446 | Q9BU23 | |
| FRMQNTLYLSLTRFI | 426 | Q8N0V4 | |
| RARLAYSLGMTESQV | 266 | P78426 | |
| YNFQLDTILRRMFSG | 501 | Q969Y0 | |
| NRLLASLFENYMSTD | 626 | Q9Y2K3 | |
| KTGTQYLLRMANRLF | 81 | P35237 | |
| MTLEAIRYSRGSLQI | 1 | Q9BV20 | |
| FTSLLMERLTGEYSR | 156 | A6NHL2 | |
| NLYSLRRMIIGSTNI | 291 | Q14191 | |
| LQGITFTRDGRYMAL | 136 | Q9P2S5 | |
| LARLEAFSRAYRSSM | 941 | Q6P1J6 | |
| AFSRAYRSSMRELVG | 946 | Q6P1J6 | |
| IYTVMLAFRSGSDNL | 86 | Q8IXU6 | |
| GFRMRRNAFSVYVLS | 56 | Q96LB1 | |
| TLRMRRYADAIFTNS | 26 | P01286 | |
| FSRVYLGLSSMLRVS | 621 | Q9Y6L6 | |
| RMSALGRSSVILLTY | 16 | Q96BI1 | |
| MSLLGRDYNSELNSL | 1 | Q495N2 | |
| MGTIDLYRSSDLYQR | 676 | Q9Y2K9 | |
| RDFDIYRLSNLMTAK | 456 | O95470 | |
| TLRRYAGMALTNLTF | 496 | P25054 | |
| SLQGAARDMLSALYR | 211 | Q9Y4C5 | |
| EVMFQSRGRLSLYIQ | 6 | Q96LM1 | |
| TNMETLYTRFGRLLA | 606 | Q16280 | |
| FENILLSSYTGRLVM | 81 | O43298 | |
| TYAMSNLFSILRGDS | 286 | P63136 | |
| LGSQYIFTEMASRVL | 166 | Q8N511 | |
| LQRQMSFASVRIGLY | 86 | P55851 | |
| STGMYLRIRSLLKNS | 681 | Q6NZY4 | |
| LMYFIVRSLRTAALG | 241 | O95070 | |
| LENYRNLFSLGMTVS | 46 | P0CB33 | |
| GVRMISLSYSRISLA | 406 | O43242 | |
| SRIYSMSLRLSAFFE | 1401 | Q8WWQ0 | |
| SAYRTLNRILTMDGL | 21 | P82921 | |
| LYVISQMLSARFSGN | 301 | P61619 | |
| RGLNASTRYLFRMRA | 706 | P35590 | |
| STRYLFRMRASIQGL | 711 | P35590 | |
| MALRARALYDFRSEN | 1 | Q96RF0 | |
| ETLRYGTSLALMNRS | 206 | Q6ZMT1 | |
| ASSRLRLLEYSAFME | 221 | Q99594 | |
| TYAMSNLFSILRGDS | 286 | P10266 | |
| TYAMSNLFSILRGDS | 286 | P63133 | |
| IYSAGDSLMIRFRTD | 976 | Q9Y6L7 | |
| SLATGDYTRAAVRMA | 376 | P11172 | |
| SGTRSLREYTLMELL | 926 | O43847 | |
| TYAMSNLFSILRGDS | 286 | Q9UQG0 | |
| LMRRAGYINEFVSIS | 561 | Q9NW08 | |
| LSTRLYETFNREMSR | 216 | O43151 | |
| MFLYNLTLQRATGIS | 1 | Q15393 | |
| TVYLLSRMGNSRSAL | 656 | P49754 | |
| FSGLSSAEMYRQVLL | 336 | Q00722 | |
| SSLSAAQRNLYREVM | 191 | Q9NZV7 | |
| SAALEKQMLRRSYFA | 786 | O43592 | |
| SLFLFRGTMYRRLQE | 286 | Q8NEE8 | |
| SGEMLANFRNIYRLS | 781 | Q5SVZ6 | |
| VRMNDGFSSYLLDIT | 181 | Q6PF06 | |
| MIDYVSNRLISRSGT | 966 | P35573 | |
| GMSGARSRNIVYFSL | 521 | Q8N8K9 | |
| LLFTASGYLSFSIMR | 271 | Q15049 | |
| RAFYRIQATRLMTGA | 361 | P32418 | |
| AFYRIQATRLMTGAG | 351 | Q9UPR5 |